Page last updated: 2024-08-23

lofexidine and buprenorphine

lofexidine has been researched along with buprenorphine in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (8.33)	18.2507
2000's	5 (41.67)	29.6817
2010's	6 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greenwood, J; Seivewright, NA	1
Alcorn, R; Feinmann, C; White, R	1
Bearn, J; de Wet, CJ; Glasper, A; Gossop, M; Reed, LJ	1
Banbery, J; Brearley, R; Finnegan, O; Raistrick, D; Thistlethwaite, G; West, D	1
Cubells, JF; Tang, YL; Zhao, C; Zhao, D	1
Ali, R; Gowing, L; White, JM	1
Meader, N	1
Bramness, J; Gossop, M; Lobmaier, P; Waal, H	1
Law, F; Melichar, J; O'Shea, J; Praveen, KT	1
Ali, R; Gowing, L; Mbewe, D; White, JM	1

Reviews

6 review(s) available for lofexidine and buprenorphine

Article	Year
What is important in drug misuse treatment? Lancet (London, England), 1996, Feb-10, Volume: 347, Issue:8998 Topics: Buprenorphine; Clonidine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom	1996
Opiate addiction in China: current situation and treatments. Addiction (Abingdon, England), 2006, Volume: 101, Issue:5 Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics	2006
Buprenorphine for the management of opioid withdrawal. The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3 Topics: Acute Disease; Buprenorphine; Clonidine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome	2009
A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug and alcohol dependence, 2010, Apr-01, Volume: 108, Issue:1-2 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Data Interpretation, Statistical; Humans; Methadone; Narcotic Antagonists; Narcotics; Odds Ratio; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome	2010
The pharmacological treatment of opioid addiction--a clinical perspective. European journal of clinical pharmacology, 2010, Volume: 66, Issue:6 Topics: Adrenergic Agonists; Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome	2010
Buprenorphine for managing opioid withdrawal. The Cochrane database of systematic reviews, 2017, 02-21, Volume: 2 Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome	2017

Trials

1 trial(s) available for lofexidine and buprenorphine

Article	Year
A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial. Addiction (Abingdon, England), 2005, Volume: 100, Issue:12 Topics: Adolescent; Adult; Buprenorphine; Clonidine; Community Mental Health Services; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome	2005

Other Studies

5 other study(ies) available for lofexidine and buprenorphine

Article	Year
Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine. Drug and alcohol dependence, 2001, Dec-01, Volume: 65, Issue:1 Topics: Adult; Buprenorphine; Chi-Square Distribution; Clonidine; Community Health Services; Female; Humans; Logistic Models; Male; Narcotic Antagonists; Opioid-Related Disorders; Outcome Assessment, Health Care; Prospective Studies; Statistics, Nonparametric; Substance Withdrawal Syndrome	2001
Induction of patients with moderately severe methadone dependence onto buprenorphine. Addiction biology, 2005, Volume: 10, Issue:2 Topics: Adult; Buprenorphine; Clonidine; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Severity of Illness Index; Surveys and Questionnaires	2005
Opioid dependence. American family physician, 2012, Sep-15, Volume: 86, Issue:6 Topics: Buprenorphine; Clonidine; Evidence-Based Medicine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prognosis; Risk Factors; Substance Withdrawal Syndrome; Time Factors	2012
Management of opioid withdrawal symptoms. The Medical letter on drugs and therapeutics, 2018, 08-27, Volume: 60, Issue:1554 Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2018
Expanded table: Some drugs for management of opioid withdrawal symptoms. The Medical letter on drugs and therapeutics, 2018, 08-27, Volume: 60, Issue:1554 Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2018